10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ELI LILLY & CO | ||
Ticker: LLY Fiscal Year: 2020 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2020 10-K (Filed: Feb 17, 2021) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2020 | Dec 31, 2019 | |
| Assets | ||
| Current Assets | ||
| Cash and cash equivalents (Note 7) | $ 3,657,100 | 2,337,500 |
| Short-term investments (Note 7) | 24,200 | 101,000 |
| Accounts receivable, net of allowances of $25.9 (2020) and $22.4 (2019) | 5,875,300 | 4,547,300 |
| Other receivables | 1,053,700 | 994,200 |
| Inventories (Note 6) | 3,980,300 | 3,190,700 |
| Prepaid expenses and other | 2,871,500 | 2,538,900 |
| Total current assets | 17,462,100 | 13,709,600 |
| Investments (Note 7) | 2,966,800 | 1,962,400 |
| Goodwill (Note 8) | 3,766,500 | 3,679,400 |
| Other intangibles, net (Note 8) | 7,450,000 | 6,618,000 |
| Deferred tax assets (Note 14) | 2,830,400 | 2,572,600 |
| Property and equipment, net (Note 9) | 8,681,900 | 7,872,900 |
| Other noncurrent assets | 3,475,400 | 2,871,200 |
| Total assets | 46,633,100 | 39,286,100 |
| Liabilities and Equity | ||
| Current Liabilities | ||
| Short-term borrowings and current maturities of long-term debt (Note 11) | 8,700 | 1,499,300 |
| Accounts payable | 1,606,700 | 1,405,300 |
| Employee compensation | 997,200 | 915,500 |
| Sales rebates and discounts | 5,853,000 | 4,933,600 |
| Dividends payable | 770,600 | 671,500 |
| Income taxes payable (Note 14) | 495,100 | 160,600 |
| Other current liabilities | 2,750,300 | 2,189,400 |
| Total current liabilities | 12,481,600 | 11,775,200 |
| Other Liabilities | ||
| Long-term debt (Note 11) | 16,586,600 | 13,817,900 |
| Accrued retirement benefits (Note 15) | 4,094,500 | 3,698,200 |
| Long-term income taxes payable (Note 14) | 3,837,800 | 3,607,200 |
| Other noncurrent liabilities | 1,707,500 | 1,501,000 |
| Deferred tax liabilities (Note 14) | 2,099,900 | 2,187,500 |
| Total other liabilities | 28,326,300 | 24,811,800 |
| Commitments and Contingencies (Note 16) | ||
| Eli Lilly and Company Shareholders' Equity (Notes 12 and 13) | ||
| Common stockno par value Authorized shares: 3,200,000 Issued shares: 957,077 (2020) and 958,056 (2019) | 598,200 | 598,800 |
| Additional paid-in capital | 6,778,500 | 6,685,300 |
| Retained earnings | 7,830,200 | 4,920,400 |
| Employee benefit trust | (3,013,200) | (3,013,200) |
| Accumulated other comprehensive loss (Note 17) | (6,496,400) | (6,523,600) |
| Cost of common stock in treasury | (55,700) | (60,800) |
| Total Eli Lilly and Company shareholders' equity | 5,641,600 | 2,606,900 |
| Noncontrolling interests | 183,600 | 92,200 |
| Total equity | 5,825,200 | 2,699,100 |
| Total liabilities and equity | 46,633,100 | 39,286,100 |
| External Links | |
| ELI LILLY & CO (LLY) Fiscal Year 2020 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |